I graduated with a master's degree from the Southern Medical University. Now I am a resident of the Cardiothoracic Surgery Center of the Affiliated Hospital of Guangdong Medical University. I am interested in the tumor immune microenvironment with immunotherapy efficacy research and bioinformatics analysis of non-small cell lung cancer.

Director of Internal Medicine, Cancer Hospital Chinese Academy of Medical Sciences
Chief Physician, Professor of Peking Union Medical College
Winner of National "Outstanding Youth" Fund
Leader of the Innovation Team of the Ministry of Education
Vice chairman, Chinese Society of Clinical Oncology (CSCO) Small Lung Cancer Professional Committee
Candidate chairman, Chinese Society of Clinical Oncology (CSCO) Non-small Lung Cancer Professional Committee
Vice Chairman, Chinese Anti-Cancer Association Lung Cancer Professional Committee

Dr Zhijie Wang is a Chief Physician for the National Cancer Center and National Clinical Research Center for Cancer in Beijing, China. He is also Chief Physician, MD Editorial Board Member of the Chinese Society of Clinical Oncology (CSCO) Guidelines for non-small cell lung cancer, member of the National Cancer Quality Control Center and National Anti-tumor Drug Surveillance System, Managing Director of the CSCO, and Vice Chairman of the China Anti-Cancer Association and the China Association for Promotion of Health Science and Technology. Dr Wang has more than 30 SCI publications as first and/or corresponding author, including the Lancet Respiratory Medicine, Journal of Clinical Oncology, JAMA Oncology, PNAS, Cancer Research, Clinical Cancer Research, and JTO. Dr Wang was also selected for the young top-notch talent of the National Ten Thousand Talent Program.

Dr. Wei Nie is a thoracic oncologist at Shanghai Chest Hospital, Department of Pulmonary Medicine. He is also the member of ASCO, CSCO, ESMO, and IASLC. His clinical and research interests are in molecular immunotherapy and targeted therapy in thoracic malignancies. He has over 60 publications including in Journal of the National Comprehensive Cancer Network, OncoImmunology, and International Journal of Cancer.

Professor Li Zhang is Professor of Medical Oncology, Director of Medical Oncology Department of Sun Yat-Sen University Cancer Centre (SYSUCC), Deputy Director of Lung Cancer Research Centre of SYSU. He is also the member of ASCO, AACR, ESMO, CSCO, IASLC, MASCC, Member of communication committee of IASLC. He received his medical and master of clinical oncology degrees from SYSU and was board certified as a physician in medical oncology. He has completed training as a visiting fellow at the MD Anderson Cancer Centre, Houston; and Institut Gustave Roussy, Paris, France.

Professor Zhang’s research interest is in the development of molecular, prognostic and therapeutic approaches to improve the care for patients with lung cancer and Nasopharyngeal carcinoma. He is also actively involved in cancer palliative and supportive care like cancer pain management and chemotherapy induced nausea and vomiting (CINV). He contributes extensively to the Chinese Anti-Cancer Association (CACA) where he currently serves as Presidents of the Committee of Rehabilitation and Palliative Care (CRPC), CACA. He is also a standing committee member of the Chinese Society of Clinical Oncology (CSCO) and President-elect of immunotherapy expert committee of CSCO.

Professor Zhang has published more than 200 clinical papers in top-tier journals like: Lancet, Lancet Oncology, Lancet Respiratory Medicine, Journal of Clinical Oncology, JAMA Oncology, Annals of Oncology, Nature communications. He also presented abstracts to many major congresses like ASCO, ESMO, WCLC, MASCC meetings. He is an editorial board member of Clinical Lung Cancer, Cancer Communications, Chinese Journal of Clinical Oncology. At present, he is a senior consultant to the Centre of Drug Evaluation (CDE), Chinese Food and Drug Administration (CFDA) and had formerly drafted the CFDA Guidance for Industry: Clinical Trial for the Approval of Cancer Drugs and Biologics (second version, 2006).